Duchenne Muscular Dystrophy (DMD) Clinical Trials

14 recruiting

Frequently Asked Questions

Common questions about Duchenne Muscular Dystrophy (DMD) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Phase 1Phase 2

A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping to Evaluate the Safety and Efficacy of ENTR-601-45

Duchenne Muscular Dystrophy (DMD)
Entrada Therapeutics, Inc.24 enrolled15 locationsNCT07038824
Recruiting
Phase 1Phase 2

A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and Efficacy of ENTR-601-44

Duchenne Muscular Dystrophy (DMD)
Entrada Therapeutics, Inc.24 enrolled14 locationsNCT07037862
Recruiting
Phase 1

A Trial to Investigate the Safety and Pharmacokinetics of GRT6019 in Healthy Male Participants

Duchenne Muscular Dystrophy (DMD)
Grünenthal GmbH24 enrolled1 locationNCT07347548
Recruiting
Not Applicable

Urinary Titin Biomarker in DMD

Duchenne Muscular Dystrophy (DMD)Becker's Muscular Dystrophy (BMD)
Children's Hospital of Philadelphia50 enrolled1 locationNCT07332013
Recruiting

Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders

Duchenne Muscular Dystrophy (DMD)Spinal Muscular Atrophy Type 3
Columbia University106 enrolled3 locationsNCT06839469
Recruiting
Not Applicable

Active NBS Study: Decentralised Monitoring Motor Development in Children With Duchenne Muscular Dystrophy or Spinal Muscular Atrophy Identified by Newborn Screening

Duchenne Muscular Dystrophy (DMD)Spinal Muscular Atrophy (SMA)
Centre Hospitalier Universitaire de Liege100 enrolled1 locationNCT07286565
Recruiting
Not Applicable

Gut Peptides and Bone Remodeling in Children With Neuromuscular Disorders

Cerebral Palsy (CP)Duchenne Muscular Dystrophy (DMD)Spinal Muscular Atrophy (SMA)
University of Copenhagen8 enrolled1 locationNCT07254988
Recruiting
Early Phase 1

Safety and Dystrophin Expression of SPOT-mRNA03 in Duchenne Muscular Dystrophy (DMD) Patients

Duchenne Muscular Dystrophy (DMD)
Shanghai Siponuoyin Biotechnology Co Ltd6 enrolled1 locationNCT07188012
Recruiting
Not Applicable

Fear of Falling in Muscular Dystrophy

RehabilitationMuscular DystrophiesFear of Falling+1 more
Universita di Verona100 enrolled1 locationNCT07129954
Recruiting

DMD Voice: Qualitative Interviews With Patients and Caregivers

Duchenne Muscular Dystrophy (DMD)
Red Nucleus Enterprise Solutions, LLC68 enrolled1 locationNCT06925269
Recruiting
Early Phase 1

Evaluation of the Safety, Tolerability, and Efficacy of LE051 in Patients With Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy (DMD)
Shanghai Jiao Tong University School of Medicine12 enrolled1 locationNCT06900049
Recruiting
Early Phase 1

Evaluation of the Safety and Efficacy of BBM-D101 to Treat Patients with Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy (DMD)
Shanghai Jiao Tong University School of Medicine6 enrolled1 locationNCT06641895
Recruiting

Follow-up of NIV At Home in Patients with Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy (DMD)
Universitaire Ziekenhuizen KU Leuven17 enrolled1 locationNCT06773988
Recruiting

Research on the Relationship Between Scoliosis, Pain, Quality of Life, and Trunk Muscle Compensation Patterns Among Patients with Duchenne Muscular Dystrophy.

Duchenne Muscular Dystrophy (DMD)
Seoul National University Hospital30 enrolled1 locationNCT06755138